1. What Are We Dealing With? 2. Patients With Posterior Segment Intraocular Inflammation (PS11). 3. Practical Evaluation of the Patient in the Clinic. 4. Instituting and Monitoring Therapy for Sight-Threatening Uveitus. 5. Immunomodulatory Therapy. 6. Research Questions.
ANDREW D. DICK is Professor and Head of Research, Department of Clinical Sciences and Academic Unit of Ophthalmology, University of Bristol and Lead clinician for regional ocular inflammatory service, Bristol Eye Hospital, UK. He received his M.D. from the University of Aberdeen, Aberdeen, UK. Dr. Dick’s research consists of the management of ocular inflammatory disease, the immunobiology of autoimmunity and transplantation, as well as retina immunity tolerance and regulation. Dr. Dick’s clinics also consist with four other consultants to deliver a regional vitreoretinal service.
ANNABELLE A. OKADA is Associate Professor of Ophthalmology at the Kyorin University School of Medicine, Tokyo, Japan, and serves as Director of both the Ocular Inflammation Service and the Macular Disease Service at the Kyorin Eye Center. Dr. Okada received her A.B. and M.D. degrees from Harvard University, and did her postgraduate training at the Massachusetts Eye and Ear Infirmary in Boston. Dr. Okada’s research interests focus on developing new treatments for various types of ocular inflammatory disease and macular degeneration.
JOHN V. FORRESTER is Cockburn Professor of Ophthalmology, University of Aberdeen, and Honorary Consultant Ophthalmologist, Aberdeen Royal Infirmary, Aberdeen, UK. Dr. Forrester received his M.D. from Glasgow University, Glasgow, UK. Dr. Forrester’s main research is in the field of ocular immunology, specifically vitreoretinal surgery, ocular inflammatory disease and diabetes, and ophthalmic imaging.